⌘K

Login Start Free

Home/Filings/4/0001493152-22-026963

4//SEC Filing

Trieu Vuong 4

Accession 0001493152-22-026963

CIK 0000908259other

View on SEC.gov Company Profile

Filed

Sep 27, 8:00 PM ET

Accepted

Sep 28, 9:15 AM ET

Size

6.1 KB

Accession

0001493152-22-026963

Insider Transaction Report

Form 4

Period: 2022-09-26

Oncotelic Therapeutics, Inc.OTLC

DirectorCHAIRMAN AND CEO10% Owner

Transactions

Purchase
Common Stock
2022-09-26$0.07/sh+20,000$1,360→ 90,368,021 total

Holdings

Common Stock
(indirect: By Autotelic, Inc.)
16,780,384
Common Stock
(indirect: By Spouse)
6,872,529

Documents

1 file

4
ownership.xmlPrimary

Issuer

Oncotelic Therapeutics, Inc.

CIK 0000908259

Entity typeother

Related Parties

1

filerCIK 0001587074

Filing Metadata

Form type: 4
Filed: Sep 27, 8:00 PM ET
Accepted: Sep 28, 9:15 AM ET
Size: 6.1 KB

View on SEC.gov